1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62B43AFD4B63A436585257AF3004ACF52
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/benchmarking-critical-program-multidisciplinary-education-trends?opendocument
18
19opendocument
2054.197.24.206
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Education

Professional Medical Education Excellence: Benchmarking Critical Program and Multidisciplinary Education Trends for the Medical Device and Biopharmaceutical Marketplace

ID: 5235


Features:

10 Info Graphics

25 Data Graphics

275+ Metrics

3 Narratives

2 Best Practices


Pages/Slides: 41


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Benchmarking Critical Program and Multidisciplinary Education Trends for the Medical Device and Biopharmaceutical Marketplace"

STUDY OVERVIEW

Given the important role of Medical Education groups and the challenging business environment they face, it's critical for organizations to continually improve the development and delivery of their education programs to improve patient outcomes. Across medical device and pharma companies, a majority of Medical Education leaders are relying more heavily on multidisciplinary programs in an effort to become more efficient and outcomes oriented.

This Best Practices, LLC study presents benchmarks and insights around the different approaches to program development and delivery as well as the utilization of professional societies/associations. There is also a chapter devoted to the use of multidisciplinary Medical Education programs and the different factors driving these emerging programs. In addition to quantitative data on all these issues, this study contains narratives from education leaders on how they are dealing with some of these challenges. Medical Education leaders can use this study to ensure they are supporting the types of programs that add value to both physicians and the company.

The data in this study are presented in two segments: Medical Device and Pharmaceutical.


KEY TOPICS

  • Universe of Learning: Key Demographics of Participating Companies
  • Program Benchmarks & Trends: Developing and Deploying Medical Education Programs
  • Educating For Better Outcomes: Multidisciplinary programs are on the Rise

SAMPLE KEY METRICS
  • Current Mix of Company-Developed versus Vendor-Developed Education Programs
  • Current Mix of Company-Delivered versus Vendor-Delivered Education Programs
  • Estimate of the Mix of Company-Delivered versus Vendor-Delivered Education Programs in the next 24-36 months
  • Estimate of the Mix of Company-Developed versus Vendor-Developed Education Programs in the next 24-36 months
  • Percentage of Company-Sponsored Accredited and Non-Accredited Education Programs presented Through Professional Societies in Most Recent Fiscal Year
  • Over the next 2-3 Years, what will be the Trend for Grants Regarding the Number of Grants to Professional Society/Associations for Accredited and Non-Accredited Programs
  • Use Multidisciplinary Programs to Support Medical Education
  • Percent of Education Supporting Multidisciplinary Programs
  • Mix of Multidisciplinary Education Programs (Accredited versus Non-Accredited)
SAMPLE KEY FINDING
  • Professional Society Utilization & Grant Trends: Both segments utilize professional societies for roughly two-thirds of their company sponsored accredited programs and one third of their non-accredited programs. Meanwhile, a majority of both segments expect society grants for accredited and non-accredited programs to either stay flat or decrease in the next 2-3 years; a quarter of both segments expect grants to decline for both program types in the same period.
METHODOLOGY

Best Practices, LLC engaged 32 Medical Education leaders at 31 companies through a benchmarking survey instrument. In addition, research analysts conducted deep-dive executive interviews with 5 selected respondents to collect qualitative data and insights. Fourteen participants represent the Medical Device Segment and 18 participants represent the Pharma Segment.

Industries Profiled:
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Health Care; Technology; Orthopaedics; Biotech; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Bayer Healthcare; Becton Dickinson; Boston Scientific; Covidien; Bard; Ethicon Endo Surgery; Medrad; Medtronic; Orthofix; Philips; Smith and Nephew; Terumo; Zimmer; Amylin; Astellas Pharma; AstraZeneca; Baxter; Boehringer Ingelheim; Novartis; Sanofi; UCB; Gilead; Esteve; Grunenthal; Insight Pharmaceuticals; Johnson & Johnson; Regeneron; Stallergenes; Xanodyne


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.